iRobot 2014 Annual Report Download - page 39

33
(1) Stock option grants vest over a four-year period, at a rate of twenty-five percent (25%) on the first anniversary of the grant, and
the remainder in equal quarterly installments thereafter.
(2) Restricted stock unit awards vest over a four-year period, at a rate of twenty-five percent (25%) on each anniversary of the grant.
(3) Amounts disclosed in this column were calculated based on the fair market value of our common stock as of December 27,
2014.
(4) Performance stock unit awards are earned over a three-year period and vest at the end of such three-year period, dependent on
achievement of pre-established performance goals and objectives. For additional information on the performance stock unit
awards see the section above entitled “ Compensation Discussion and Analysis - Elements of Compensation - Long-Term
Incentives.”
(5) The stock options granted to Dr. Pirjanian on October 1, 2012 were granted as replacement awards for unvested stock options
that Dr. Pirjanian held in Evolution Robotics, Inc. as of the date that the Company acquired Evolution Robotics, Inc.
Option Exercises and Stock Vested
The following table sets forth, for each of the named executive officers, information with respect to the exercise of stock options
and the vesting of restricted stock unit awards during the year ended December 27, 2014.
OPTION EXERCISES AND STOCK VESTED — 2014
Option Awards Stock Awards
Name
Shares
Acquired on
Exercise(#)
Value
Realized on
Exercise($)
(1)
Number of Shares
Acquired on
Vesting(#)
Value
Realized on
Vesting($)
(2)
Colin M. Angle 47,333 1,032,279 50,138 2,157,317
Alison Dean 18,970 481,229 9,981 406,909
Russell J. Campanello 20,000 259,400 16,945 664,342
Christian D. Cerda — — 7,500 324,600
Paolo Pirjanian 21,306 484,123 10,457 392,054
(1) Amounts disclosed in this column were calculated based on the difference between the fair market value of our common stock
on the date of exercise and the exercise price of the options in accordance with regulations promulgated under the Exchange Act.
(2) Amounts disclosed in this column were calculated based on the fair market value of the shares on the date of settlement upon
vesting.
Potential Benefits Upon Termination or Change in Control
Severance and Change in Control Arrangements in General
The Company has entered into executive agreements with each of the named executive officers, the terms of which are
described in the “Compensation Discussion and Analysis” section above.
Cash Payments and/or Acceleration of Vesting Following Certain Termination Events
Assuming the employment of our named executive officers was terminated without cause (not in connection with a change in
control) on December 27, 2014, our named executive officers would be entitled to cash payments in the amounts set forth opposite
their names in the table below, subject to any deferrals required under Section 409A of the Code.
Name
Base
Salary
($)
Continuation of
Health Plan
Premium
Payments ($) Total ($)
Colin Angle 325,000 10,023 335,023
Alison Dean 200,000 8,947 208,947
Russ Campanello 162,500 10,023 172,523
Christian Cerda 175,000 10,023 185,023
Paolo Pirjanian 175,000 10,023 185,023
Proxy Statement